Hot Features
Premium
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Period:
Draw Mode:
| Volume | 186,033 |
|
|||||
| News | - | ||||||
| Day High | 0.4386 | Low High |
|||||
| Day Low | 0.388 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Apollomics Inc | APLM | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.41 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.4074 | 0.388 | 0.4386 | 0.3965 | 0.41 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 603 | 186,033 | US$ 0.3978965 | US$ 74,022 | - | 0.388 - 6.45 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:29:07 | 48 | US$ 0.41 | USD |
Apollomics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 34.72M | 86.80M | - | 1.45M | -240.81M | -2.77 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Apollomics News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical APLM Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.457 | 0.49 | 0.388 | 0.4325596 | 190,595 | -0.047 | -10.28% |
| 1 Month | 0.5879 | 0.61 | 0.388 | 0.4889779 | 185,230 | -0.1779 | -30.26% |
| 3 Months | 0.70 | 0.805 | 0.388 | 0.5973443 | 176,725 | -0.29 | -41.43% |
| 6 Months | 0.7331 | 1.79 | 0.388 | 0.8888165 | 1,120,723 | -0.3231 | -44.07% |
| 1 Year | 4.45 | 6.45 | 0.388 | 0.9694898 | 1,000,007 | -4.04 | -90.79% |
| 3 Years | 18.60 | 49.00 | 0.388 | 1.31 | 943,772 | -18.19 | -97.80% |
| 5 Years | 18.60 | 49.00 | 0.388 | 1.31 | 943,772 | -18.19 | -97.80% |
Apollomics Description
| Apollomics, Inc., a biotechnology company, engages in the discovery and development of oncology therapies to address unmet medical needs in California, Hangzhou, Shanghai, China, and Australia. It develops APL-101 (Vebreltinib), a potent, selective c-Met inhibitor for the treatment of non-small cell lung cancer and other advanced tumors; APL-102 is an oral active, small molecule multiple tyrosine kinase inhibitor for liver cancer, breast cancer, and esophageal cancer; and APL-122, a tumor inhibitor candidate to treat cancers within the brain. The company was formerly known as CBT Pharmaceuticals, Inc. and changed its name to Apollomics, Inc. in January 2019. Apollomics, Inc. was incorporated in 2015 and is based in Foster City, California. |
